Decitabine in combination with low-dose cytarabine, aclarubicin and G-CSF tends to improve prognosis in elderly patients with high-risk AML-Reference-Cited by-同舟云学术

Decitabine in combination with low-dose cytarabine, aclarubicin and G-CSF tends to improve prognosis in elderly patients with high-risk AML

Published:2020-04-01 Issue:7 Volume:12 Page:5792-5811
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Hong Ming¹²³,Zhu Han¹²³,Sun Qian¹²³,Zhu Yu¹²³,Miao Yi¹²³,Yang Hui¹²³,Qiu Hai-Rong¹²³,Li Jian-Yong¹²³,Qian Si-Xuan¹²³

Affiliation:

1. Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, Jiangsu Province, China

2. Key Laboratory of Hematology of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China

3. The Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, Jiangsu Province, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Butterfly Effect in Cytarabine: Combined NMR-NQR Experiment, Solid-State Computational Modeling, Quantitative Structure-Property Relationships and Molecular Docking Study;Pharmaceuticals;2024-03-29

2. Low‑dose venetoclax combined with azacitidine in older and frail patients with newly diagnosed acute myeloid leukaemia;Oncology Letters;2024-03-26

3. Venetoclax plus a hypomethylating agent versus cytarabine, aclarubicin, and granulocyte colony‐stimulating factor chemotherapy as a first‐line therapy for newly diagnosed acute myeloid leukemia: A propensity score–matched analysis;Cancer;2024-03-12

4. Effect of low skeletal muscle mass on NK cells in patients with acute myeloid leukemia and its correlation with prognosis;Annals of Hematology;2024-01-31

5. RETRACTED ARTICLE: The predictive value of BTG1 for the response of newly diagnosed acute myeloid leukemia to decitabine;Clinical Epigenetics;2024-01-22